Literature DB >> 24430575

Association of miR-146a gene polymorphism with risk of nasopharyngeal carcinoma in the central-southern Chinese population.

Guo-Liang Huang1, Mei-Ling Chen2, Ya-Zhen Li2, Yan Lu1, Xing-Xiang Pu3, Yu-Xiang He4, Shu-Yin Tang2, Hua Che2, Ying Zou1, Congcong Ding1, Zhiwei He1.   

Abstract

This case-control study focused on estimating the association between miR-146a polymorphism and risk of nasopharyngeal carcinoma (NPC) in central-south China. In total, 160 patients with NPC and 200 healthy controls in central-south China were genotyped using polymerase chain reaction-restriction fragment length polymorphism assay. Chi-square test was used to assess the different distribution of miR-146a polymorphism between NPC patients and controls; and logistic regression analysis was applied to analyze the associations between miR-146a polymorphism with cancer risk in different contrast models. Significant differences between NPC patients and controls were found in genotype (P=0.033 for GG versus CG versus CC; and odds ratio (OR)=0.568, 95% confidence interval (CI)=0.354-0.912, P=0.019 for CG versus CC; and OR=0.503, 95% CI=0.261-0.971, P=0.041 for CG versus CC; and OR=0.564, 95% CI=0.360-0.884, P=0.012 for GG+CG versus CC, respectively) and allelic analysis (P=0.025 for G versus C). Our findings suggested that polymorphism of mir-146a was associated with NPC in the central-southern Chinese population.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24430575     DOI: 10.1038/jhg.2013.135

Source DB:  PubMed          Journal:  J Hum Genet        ISSN: 1434-5161            Impact factor:   3.172


  50 in total

1.  The 5' regulatory sequences of active miR-146a promoters are hypomethylated and associated with euchromatic histone modification marks in B lymphoid cells.

Authors:  Kalman Szenthe; Anita Koroknai; Ferenc Banati; Zoltan Bathori; Rita Lozsa; Jozsef Burgyan; Hans Wolf; Daniel Salamon; Katalin Nagy; Hans Helmut Niller; Janos Minarovits
Journal:  Biochem Biophys Res Commun       Date:  2013-03-23       Impact factor: 3.575

2.  The prognostic impact of microRNA sequence polymorphisms on the recurrence of patients with completely resected non-small cell lung cancer.

Authors:  Kyong-Ah Yoon; Hyekyoung Yoon; Sohee Park; Hee-Jin Jang; Jae Ill Zo; Hyun-Sung Lee; Jin Soo Lee
Journal:  J Thorac Cardiovasc Surg       Date:  2012-07-18       Impact factor: 5.209

3.  53BP1 functions as a tumor suppressor in breast cancer via the inhibition of NF-κB through miR-146a.

Authors:  Xiaoyan Li; Bing Xu; Meena S Moran; Yuhan Zhao; Peng Su; Bruce G Haffty; Changshun Shao; Qifeng Yang
Journal:  Carcinogenesis       Date:  2012-10-01       Impact factor: 4.944

4.  Association between the rs2910164 polymorphism in pre-mir-146a and oral carcinoma progression.

Authors:  Pei-Shi Hung; Kuo-Wei Chang; Shou-Yen Kao; Ting-Hui Chu; Chung-Ji Liu; Shu-Chun Lin
Journal:  Oral Oncol       Date:  2011-12-17       Impact factor: 5.337

5.  Genetic variants in miR-146a, miR-149, miR-196a2, miR-499 and their influence on relative expression in lung cancers.

Authors:  Serena Vinci; Stefania Gelmini; Nicola Pratesi; Simona Conti; Francesca Malentacchi; Lisa Simi; Mario Pazzagli; Claudio Orlando
Journal:  Clin Chem Lab Med       Date:  2011-09-09       Impact factor: 3.694

6.  MDM2 promoter SNP309 is associated with risk of occurrence and advanced lymph node metastasis of nasopharyngeal carcinoma in Chinese population.

Authors:  Gangqiao Zhou; Yun Zhai; Ying Cui; Xiumei Zhang; Xiaojia Dong; Hao Yang; Ying He; Kaitai Yao; Hongxing Zhang; Lianteng Zhi; Xiaoyan Yuan; Wei Qiu; Xiaoai Zhang; Yan Shen; Boqing Qiang; Fuchu He
Journal:  Clin Cancer Res       Date:  2007-05-01       Impact factor: 12.531

7.  Genome-wide scan for familial nasopharyngeal carcinoma reveals evidence of linkage to chromosome 4.

Authors:  Bing-Jian Feng; Wei Huang; Yin Yao Shugart; Ming K Lee; Feng Zhang; Jian-Chuan Xia; Hui-Yun Wang; Teng-Bo Huang; Shao-Wen Jian; Ping Huang; Qi-Sheng Feng; Li-Xi Huang; Xing-Juan Yu; Duang Li; Li-Zheng Chen; Wei-Hua Jia; Yan Fang; Hui-Ming Huang; Jing-Liu Zhu; Xiao-Ming Liu; Yan Zhao; Wang-Qing Liu; Mang-Quan Deng; Wei-Han Hu; Shao-Xiong Wu; Hao-Yuan Mo; Ming-Fang Hong; Mary Claire King; Zhu Chen; Yi-Xin Zeng
Journal:  Nat Genet       Date:  2002-07-15       Impact factor: 38.330

8.  A functional variant in microRNA-146a promoter modulates its expression and confers disease risk for systemic lupus erythematosus.

Authors:  Xiaobing Luo; Wanling Yang; Dong-Qing Ye; Huijuan Cui; Yan Zhang; Nattiya Hirankarn; Xiaoxia Qian; Yuanjia Tang; Yu Lung Lau; Niek de Vries; Paul Peter Tak; Betty P Tsao; Nan Shen
Journal:  PLoS Genet       Date:  2011-06-30       Impact factor: 5.917

Review 9.  The emerging role of MIR-146A in the control of hematopoiesis, immune function and cancer.

Authors:  Catherine Labbaye; Ugo Testa
Journal:  J Hematol Oncol       Date:  2012-03-27       Impact factor: 17.388

10.  Aberrant expression of oncogenic and tumor-suppressive microRNAs in cervical cancer is required for cancer cell growth.

Authors:  Xiaohong Wang; Shuang Tang; Shu-Yun Le; Robert Lu; Janet S Rader; Craig Meyers; Zhi-Ming Zheng
Journal:  PLoS One       Date:  2008-07-02       Impact factor: 3.240

View more
  12 in total

Review 1.  MicroRNA variants as genetic determinants of bone mass.

Authors:  Neha S Dole; Anne M Delany
Journal:  Bone       Date:  2015-12-23       Impact factor: 4.398

Review 2.  Association between miR-146a rs2910164 polymorphism and specific cancer susceptibility: an updated meta-analysis.

Authors:  Xia Hao; Lingzi Xia; Ruoyi Qu; Xianglin Yang; Min Jiang; Baosen Zhou
Journal:  Fam Cancer       Date:  2018-07       Impact factor: 2.375

3.  The occurrence of cervical cancer in Uygur women in Xinjiang Uygur Autonomous Region is correlated to microRNA-146a and ethnic factor.

Authors:  Li Ma; Yi Hong; Chang Lu; Yanxia Chen; Cailing Ma
Journal:  Int J Clin Exp Pathol       Date:  2015-08-01

4.  Analysis for the mechanism between the small cell lung cancer and non-small cell lung cancer combing the miRNA and mRNA expression profiles.

Authors:  Weisan Zhang; Qiang Zhang; Mingpeng Zhang; Yun Zhang; Fengtan Li; Ping Lei
Journal:  Thorac Cancer       Date:  2015-01-07       Impact factor: 3.500

5.  MiR-506 suppresses tumor proliferation and invasion by targeting FOXQ1 in nasopharyngeal carcinoma.

Authors:  Zhanchi Zhang; Jun Ma; Guang Luan; Lin Kang; Yuhong Su; Yanan He; Feng Luan
Journal:  PLoS One       Date:  2015-04-09       Impact factor: 3.240

6.  Association between a miRNA-146a polymorphism and susceptibility to head and neck squamous cell carcinoma in Chinese patients: A meta-analysis of 8 case-control studies.

Authors:  Silin Zhang; Fangling Hu; Hongxing Liang; Yuanzhou Liu; Jianqiang Yang; Wensheng Zhou
Journal:  PLoS One       Date:  2017-10-19       Impact factor: 3.240

7.  MiR-146a rs2910164 polymorphism and head and neck carcinoma risk: a meta-analysis based on 10 case-control studies.

Authors:  Zhaolan Xiang; Jue Song; Xianlu Zhuo; Qi Li; Xueyuan Zhang
Journal:  Oncotarget       Date:  2017-01-03

8.  MicroRNA‑205 promotes the tumorigenesis of nasopharyngeal carcinoma through targeting tumor protein p53-inducible nuclear protein 1.

Authors:  Guohui Nie; Hongfang Duan; Xiaoqing Li; Zhendong Yu; Liang Luo; Ruijing Lu; Ziliang Ji; Wei Zhang
Journal:  Mol Med Rep       Date:  2015-08-05       Impact factor: 2.952

9.  Functional analysis of the nasopharyngeal carcinoma primary tumor‑associated gene interaction network.

Authors:  Fengwei An; Zhiqiang Zhang; Ming Xia
Journal:  Mol Med Rep       Date:  2015-07-20       Impact factor: 2.952

10.  Detection of nasopharyngeal carcinoma susceptibility with single nucleotide polymorphism analysis using next-generation sequencing technology.

Authors:  Mu-Yun Wu; Shu-Jing Huang; Fan Yang; Xin-Tian Qin; Dong Liu; Ying Ding; Shu Yang; Xi-Cheng Wang
Journal:  Oncotarget       Date:  2017-04-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.